# Evaluation of Efficacy and Safety of Two New Formulations Compared to Gynomax® XL Ovule

> **NCT06056947** · PHASE3 · COMPLETED · sponsor: **Ege University** · enrollment: 577 (actual)

## Conditions studied

- Trichomonal Vaginitis
- Bacterial Vaginosis
- Candidal Vulvovaginitis
- Mixed Vaginal Infections

## Interventions

- **DRUG:** EVEGYN A
- **DRUG:** EVEGYN B
- **DRUG:** Gynomax® XL Vaginal Ovule

## Key facts

- **NCT ID:** NCT06056947
- **Lead sponsor:** Ege University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-07-20
- **Primary completion:** 2021-05-06
- **Final completion:** 2021-08-26
- **Target enrollment:** 577 (ACTUAL)
- **Last updated:** 2023-09-28

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06056947

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06056947, "Evaluation of Efficacy and Safety of Two New Formulations Compared to Gynomax® XL Ovule". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT06056947. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*